高级检索
当前位置: 首页 > 详情页

Targeting neuroinflammation: The therapeutic potential of omega-3 PUFAs in substance abuse.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ SSCI

机构: [1]Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Medicine, Hunan, China. [2]College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. [3]Guangdong-Hongkong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, China. [4]Xinxiang Key Laboratory of Forensic Toxicology, School of Forensic Medicine, Xinxiang Medical University, Xinxiang, China. [5]Department of Metabolic Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen, China. [6]Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China
出处:
ISSN:

关键词: Astrocytes Microglia Neuroinflammation Substance abuse ω-3 PUFAs

摘要:
Substance abuse is a chronic relapsing disorder that results in serious health and socioeconomic issues worldwide. Addictive drugs induce long-lasting morphologic and functional changes in brain circuits and account for the formation of compulsive drug-seeking and drug-taking behaviors. Yet, there remains a lack of reliable therapy. In recent years, accumulating evidence indicated that neuroinflammation was implicated in the development of drug addiction. Findings from both our and other laboratories suggest that ω-3 polyunsaturated fatty acids (PUFAs) are effective in treating neuroinflammation-related mental diseases, and indicate that they could exert positive effects in treating drug addiction. Thus, in the present review, we summarized and evaluated recently published articles reporting the neuroinflammation mechanism in drug addiction and the immune regulatory ability of ω-3 PUFAs. We also sought to identify some of the challenges ahead in the translation of ω-3 PUFAs into addiction treatment. Copyright © 2020 Elsevier Inc. All rights reserved.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 3 区 营养学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 营养学
JCR分区:
出版当年[2019]版:
Q2 NUTRITION & DIETETICS
最新[2023]版:
Q2 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Medicine, Hunan, China.
通讯作者:
通讯机构: [1]Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Medicine, Hunan, China. [6]Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China [*1]Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China [*2]Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Medicine, Hunan, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号